Showing 7061-7070 of 10226 results for "".
- New Initiative Seeks To Raise Biosimilar Awareness, Accesshttps://practicaldermatology.com/news/new-initiative-to-raise-biosimilar-awareness-access/2458689/The Biosimilars Forum is launching a new biosimilars education initiative. The Partnership for Biosimilars Education and Access will focus on raising awareness and encouraging access to biosimilars in the United States. The Forum
- Sweet Acne Cure: Kanuka Honey from New Zealand May Eradicate Acnehttps://practicaldermatology.com/news/sweet-acne-cure-kanuka-honey-from-new-zealand-may-eradicate-acne/2458693/Kanuka honey may help out the brakes on acne, new research suggests. In the study of Honevo®, developed by New Zealand pharmaceutical company HoneyLab, twice as many participants had an imp
- Dr. Bruce Strober Appointed Chair of Dermatology at UConn Healthhttps://practicaldermatology.com/news/dr-bruce-strober-appointed-chair-of-dermatology-at-uconn-health/2458694/Bruce E. Strober, MD, PhD has been appointed chair of the Department of Dermatology at UConn Health and professor of dermatology at UConn School of Medicine. Dr. Strober has served as the interim chair of the Department of Dermatology since 2015 and vice chair since joining UConn Health in 2011.
- Hidradenitis Suppurativa Ups Risk of Adverse CV Eventshttps://practicaldermatology.com/news/hidradenitis-suppurativa-ups-risk-of-adverse-cv-events/2458696/Hidradenitis suppurativa (HS) may increase risk for adverse cardiovascular outcomes, a new study suggests. HS has been associated with cardiovascular risk factors, such as smoking and obesity, but the risk of cardiovascular disease in patients with HS was unknown. The new study
- Sturge-Weber Foundation to Host Dermatology Roundtablehttps://practicaldermatology.com/news/sturge-weber-foundation-to-host-dermatology-roundtable/2458697/The Sturge-Weber Foundation (SWF) is holding a Dermatology Discussion Roundtable meeting on March 5, 2016, at the Marriott Marquis in Washington, DC. Attendees of the American Academy of Dermatology (AAD) conference are invited to attend this breakfast meeting from 7:30 a.m. to 9:30 a.m. in the J
- Endo International Launches New Phase 2b Study of CCH for Cellulitehttps://practicaldermatology.com/news/endo-international-launches-new-phase-2b-study-of-cch-for-cellulite/2458699/A Phase 2b study of collagenase clostridium histolyticum (CCH) for the treatment of as cellulite is about to get started, Endo International plc reports. CCH is intended to target and lyse collagen tethers with the goal of releasing the skin di
- Interferon Not Beneficial for Most Stage III Melanomahttps://practicaldermatology.com/news/interferon-not-beneficial-for-most-stage-iii-melanoma/2458703/Most stage III melanoma patients do not benefit from treatment with interferon, according to final results for the Sunbelt Melanoma Trial, published online in the Jour
- Biosimilar News: Sandoz Acquires Biosimilar Infliximab In EEA, FDA Panel Urges Approval of Biosimilar Infliximab in UShttps://practicaldermatology.com/news/biosimilar-new-sandoz-acquires-biosimilar-infliximab-in-eea-fda-panel-urges-approval-of-biosimilar-infliximab-in-us/2458705/Two days after a US Food and Drug Administration (FDA) advisory panel voted to recommend approval of the biosimilar form of Remicade (Infliximab), Novartis’ Sandoz unit has acquired rights to develop and commercialize a biosimilar to Remicade® (i
- Weleda Partners with NonProfit Group Offering Free Makeovers for Seniorshttps://practicaldermatology.com/news/weleda-gives-back-with-complimentary-makeovers-for-seniors/2458706/Natural skin care company Weleda is partnering with GlamourGals, a nonprofit group that provides complimentary beauty makeovers to senior citizens. Weleda will provide more than 7,000 tubes of Skin Fo
- Study Shows Novel Effects of Eucerin Active Ingredient Complex on Atopic Dermatitishttps://practicaldermatology.com/news/study-shows-novel-effects-of-eucerin-active-ingredient-complex-on-atopic-dermatitis/2458717/Beiersdorf researchers in collaboration with the Dermatological Clinic of the University of Lübeck have shown in a double-blind clinical study that the AtopiControl ingredient complex including licochalcone, a from the licorice root and omega-6 fatty acids from evening primros